Literature DB >> 33535148

Monitoring and modulating O-GlcNAcylation: assays and inhibitors of O-GlcNAc processing enzymes.

Matthew G Alteen1, Hong Yee Tan1, David J Vocadlo2.   

Abstract

O-linked N-acetylglucosamine (O-GlcNAc) is protein modification that is emerging as a regulator of diverse aspects of cellular physiology. Aberrant O-GlcNAcylation has been linked to several diseases, spurring the creation of methods to detect and perturb the activity of the two enzymes that govern this modification - O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA). Here we summarize assays used for these two enzymes. We also detail the latest structure-guided development of inhibitors of these two enzymes and touch on selected reports that underscore the utility of inhibitors as tools for uncovering the diverse roles of O-GlcNAc in cell function. Finally, we summarize recent reports on the potential therapeutic benefits of antagonizing these enzymes and comment on outstanding challenges within the field.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2021        PMID: 33535148     DOI: 10.1016/j.sbi.2020.12.008

Source DB:  PubMed          Journal:  Curr Opin Struct Biol        ISSN: 0959-440X            Impact factor:   6.809


  10 in total

1.  Thermal Proteome Profiling Reveals the O-GlcNAc-Dependent Meltome.

Authors:  Dustin T King; Jesús E Serrano-Negrón; Yanping Zhu; Christopher L Moore; Matthew D Shoulders; Leonard J Foster; David J Vocadlo
Journal:  J Am Chem Soc       Date:  2022-03-01       Impact factor: 15.419

Review 2.  Tools, tactics and objectives to interrogate cellular roles of O-GlcNAc in disease.

Authors:  Charlie Fehl; John A Hanover
Journal:  Nat Chem Biol       Date:  2021-12-21       Impact factor: 16.174

Review 3.  O-GlcNAcylation: The Underestimated Emerging Regulators of Skeletal Muscle Physiology.

Authors:  Yang Liu; Ya-Jie Hu; Wen-Xuan Fan; Xin Quan; Bin Xu; Shi-Ze Li
Journal:  Cells       Date:  2022-05-30       Impact factor: 7.666

4.  Benzo[d]thiazol-5-yl Compounds as O-GlcNAcase Inhibitors for Treating Alzheimer's Disease.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2021-05-18       Impact factor: 4.632

5.  Regulation of the urea cycle by CPS1 O-GlcNAcylation in response to dietary restriction and aging.

Authors:  Jing Wu; Jiayu Liu; Kalina Lapenta; Reina Desrouleaux; Min-Dian Li; Xiaoyong Yang
Journal:  J Mol Cell Biol       Date:  2022-07-05       Impact factor: 8.185

6.  Shiga toxin (Stx) type 2-induced increase in O-linked N-acetyl glucosamine protein modification: a new therapeutic target?

Authors:  Rebecca A Bova; Angela Melton-Celsa
Journal:  EMBO Mol Med       Date:  2021-12-22       Impact factor: 12.137

Review 7.  O-GlcNAcylation in Chronic Lymphocytic Leukemia and Other Blood Cancers.

Authors:  David E Spaner
Journal:  Front Immunol       Date:  2021-11-18       Impact factor: 7.561

8.  O-GlcNAcylation regulates epidermal growth factor receptor intracellular trafficking and signaling.

Authors:  Liming Wu; Yaxian Cheng; Didi Geng; Zhiya Fan; Bingyi Lin; Qiang Zhu; Jingchao Li; Weijie Qin; Wen Yi
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-03       Impact factor: 12.779

Review 9.  O-GlcNAcylation: An Emerging Protein Modification Regulating the Hippo Pathway.

Authors:  Eunah Kim; Jeong Gu Kang; Eek-Hoon Jho; Won Ho Yang; Jin Won Cho
Journal:  Cancers (Basel)       Date:  2022-06-18       Impact factor: 6.575

Review 10.  Mechanistic roles for altered O-GlcNAcylation in neurodegenerative disorders.

Authors:  Aaron T Balana; Matthew R Pratt
Journal:  Biochem J       Date:  2021-07-30       Impact factor: 3.766

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.